Kite Pharma Inc (KITE) is Trading Higher on Unusual Volume for January 15

Equities Staff |

Kite Pharma Inc (KITE) experienced unusually high volume on Jan. 15, as the stock gained 0.43% to a closing price of $55.16. The stock saw 1.85 million shares trade hands over the course of the day on 16,383 trades. Given that the stock’s average daily volume over the last month has been 1.1 million shares a day, this represents a pretty substantial spike over the norm.

Kite Pharma Inc has a P/B ratio of 6.73. The stock has traded between $89.84 and $44.01 over the last 52-weeks, its 50-day SMA is now $69.99, and its 200-day SMA $63.14.

Kite Pharma Inc is a clinical-stage bio pharmaceutical company focused on the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient's own immune system to eradicate cancer cells.

Headquartered in Santa Monica, CA, Kite Pharma Inc has 116 employees and is currently under the leadership of CEO Arie S. Belldegrun.

For a complete fundamental analysis analysis of Kite Pharma Inc, check out Equities.com’s Stock Valuation Analysis report for KITE. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

THE IMPORTANCE OF THE RUSSELL 3000

The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

H-Source Holdings Ltd.

H-Source Holdings Inc. is a technology company operating within the healthcare industry through its subsidiary, H-Source, Inc. The Company has developed a transaction platform that provides a private, secure and…

Private Markets

Trustify

Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…

Cloudera

Cloudera offers enterprises a new data platform built on the Apache Hadoop open-source software package. Hadoop is a data-management platform that can consolidate data in a single repository for comprehensive…